Objectives: Endoscopic resection (ER) of high-grade dysplasia (HGD) or intramucosal cancer (IMC) in Barrett's esophagus (BE) is an effective and safe alternative to surgical treatment. After ER as monotherapy, recurrent lesions may develop elsewhere in the residual BE during follow-up (FU). Stepwise radical endoscopic resection (SRER) allows for removal of the whole BE by subsequent ERs with histological correlation and has been shown effective and safe in small-sized single-center studies. The aim of this study was to evaluate the efficacy and safety of SRER for BE-HGD/IMC in 4 European tertiary referral centres that used a prospective SRER protocol in the past years
Background The use of endoscopic submucosal dissection (ESD) is gradually expanding for treatment of...
High-grade dysplasia (HGD) and intramucosal carcinoma (IMC) in Barrett's esophagus (BE) are now well...
Background and Aims Focal EMR followed by radiofrequency ablation (f-EMR + RFA) and stepwise or comp...
Background and study aims: The aim of this retrospective study was to assess safety and efficacy of ...
Objective: After focal endoscopic resection (ER) of high-grade dysplasia (HGD) or early cancer (EC) ...
Background and Aims Endoscopic resection is safe and effective to remove early neoplasia (ie, high-g...
Background: Endoscopic therapy for early neoplasia in Barrett’s esophagus (BE) is evolving. Endoscop...
BACKGROUND AND AIMS: Stepwise radical endoscopic resection (SRER) has shown to be effective in eradi...
Focal endoscopic resection (ER) followed by radiofrequency ablation (RFA) safely and effectively era...
AbstractBackground: Endoscopic resection (ER) is emerging as a curative technique in patients with h...
Background and Aims: Early neoplasia in Barrett's esophagus (BE) can be effectively and safely remov...
Barrett’s oesophagus (BE), a known complication of gastroesophageal reflux disease, is characterised...
BACKGROUND: Endoscopic resection and radiofrequency ablation are now established therapies for high-...
Background and study aim: Endoscopic resection with radiofrequency ablation (RFA) 6 weeks later safe...
Objective The use of endoscopic submucosal dissection (ESD) is gradually expanding for treatment of ...
Background The use of endoscopic submucosal dissection (ESD) is gradually expanding for treatment of...
High-grade dysplasia (HGD) and intramucosal carcinoma (IMC) in Barrett's esophagus (BE) are now well...
Background and Aims Focal EMR followed by radiofrequency ablation (f-EMR + RFA) and stepwise or comp...
Background and study aims: The aim of this retrospective study was to assess safety and efficacy of ...
Objective: After focal endoscopic resection (ER) of high-grade dysplasia (HGD) or early cancer (EC) ...
Background and Aims Endoscopic resection is safe and effective to remove early neoplasia (ie, high-g...
Background: Endoscopic therapy for early neoplasia in Barrett’s esophagus (BE) is evolving. Endoscop...
BACKGROUND AND AIMS: Stepwise radical endoscopic resection (SRER) has shown to be effective in eradi...
Focal endoscopic resection (ER) followed by radiofrequency ablation (RFA) safely and effectively era...
AbstractBackground: Endoscopic resection (ER) is emerging as a curative technique in patients with h...
Background and Aims: Early neoplasia in Barrett's esophagus (BE) can be effectively and safely remov...
Barrett’s oesophagus (BE), a known complication of gastroesophageal reflux disease, is characterised...
BACKGROUND: Endoscopic resection and radiofrequency ablation are now established therapies for high-...
Background and study aim: Endoscopic resection with radiofrequency ablation (RFA) 6 weeks later safe...
Objective The use of endoscopic submucosal dissection (ESD) is gradually expanding for treatment of ...
Background The use of endoscopic submucosal dissection (ESD) is gradually expanding for treatment of...
High-grade dysplasia (HGD) and intramucosal carcinoma (IMC) in Barrett's esophagus (BE) are now well...
Background and Aims Focal EMR followed by radiofrequency ablation (f-EMR + RFA) and stepwise or comp...